Literature DB >> 27679584

Effect of Empagliflozin on Left Ventricular Mass and Diastolic Function in Individuals With Diabetes: An Important Clue to the EMPA-REG OUTCOME Trial?

Subodh Verma1, Ankit Garg2, Andrew T Yan3, Anup K Gupta4, Mohammed Al-Omran5, Andre Sabongui4, Hwee Teoh6,7, C David Mazer8, Kim A Connelly3.   

Abstract

Entities:  

Year:  2016        PMID： 27679584     DOI： 10.2337/dc16-1312

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  73 in total

Review 1.  Heart failure in patients with type 2 diabetes mellitus: assessment with echocardiography and effects of antihyperglycemic treatments.

Authors:  Katsuomi Iwakura
Journal:  J Echocardiogr       Date:  2019-10-15

Review 2.  SGLT2 inhibition and heart failure-current concepts.

Authors:  Joaquim Silva Custodio; Andre Rodrigues Duraes; Marconi Abreu; Natalia Albuquerque Rocha; Leonardo Roever
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

3.  Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.

Authors:  Senthil Selvaraj; Daniel P Kelly; Kenneth B Margulies
Journal:  Circulation       Date:  2020-06-01       Impact factor: 29.690

Review 4.  SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review.

Authors:  Subodh Verma; John J V McMurray
Journal:  Diabetologia       Date:  2018-08-22       Impact factor: 10.122

Review 5.  Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.

Authors:  Yuliya Lytvyn; Petter Bjornstad; Jacob A Udell; Julie A Lovshin; David Z I Cherney
Journal:  Circulation       Date:  2017-10-24       Impact factor: 29.690

Review 6.  Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents.

Authors:  Antonino Di Pino; Ralph A DeFronzo
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

7.  Empagliflozin and left ventricular diastolic function following an acute coronary syndrome in patients with type 2 diabetes.

Authors:  Nick S R Lan; Bu B Yeap; P Gerry Fegan; Gillian Green; James M Rankin; Girish Dwivedi
Journal:  Int J Cardiovasc Imaging       Date:  2020-09-21       Impact factor: 2.357

8.  Examining the Relationship and Prognostic Implication of Diabetic Status and Extracellular Matrix Expansion by Cardiac Magnetic Resonance.

Authors:  Mohammad A Khan; Eric Y Yang; Duc T Nguyen; Faisal Nabi; Jeremy Hinojosa; Maria Jabel; Sherif F Nagueh; Edward A Graviss; Dipan J Shah
Journal:  Circ Cardiovasc Imaging       Date:  2020-07-15       Impact factor: 7.792

Review 9.  Promising roles of sodium-glucose cotransporter 2 inhibitors in heart failure prevention and treatment.

Authors:  Atsushi Tanaka; Koichi Node
Journal:  Diabetol Int       Date:  2020-06-11

Review 10.  Potential impact of SGLT2 inhibitors on left ventricular diastolic function in patients with diabetes mellitus.

Authors:  Hidekazu Tanaka; Ken-Ichi Hirata
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.